Congratulations to Lunarsum Pharmaceuticals on the National Medical Products Administration Approval of Famotidine Injection!

News Center / Company news

Congratulations to Lunarsum Pharmaceuticals on the National Medical Products Administration Approval of Famotidine Injection!

2024.08.05

Lunarsum Pharma's Famotidine Injection has been officially approved for marketing.

Approval Number: H20244490

We welcome your inquiries and cooperation!

Prev：Congratulations to Lunarsun on the Successful Status Upgrade of Mirabegron to “Active”!

Return

More

Welcome to Shanghai CPHI Exhibition!

Our new website has launched on December 26, 2024.

Congratulations to Lunarsun Pharmaceuticals on the National Medical Products Administration approval of Tigecycline for Injection!